Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Merit Medical Systems (MMSI) EBIT Margin (2016 - 2025)

Merit Medical Systems (MMSI) has disclosed EBIT Margin for 16 consecutive years, with 13.76% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 3843.0% to 13.76% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 12.19% through Dec 2025, up 986.0% year-over-year, with the annual reading at 12.19% for FY2025, 986.0% up from the prior year.
  • EBIT Margin hit 13.76% in Q4 2025 for Merit Medical Systems, up from 11.09% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 13.76% in Q4 2025 to a low of 24.67% in Q4 2024.
  • Historically, EBIT Margin has averaged 4.86% across 5 years, with a median of 8.38% in 2022.
  • Biggest five-year swings in EBIT Margin: crashed -2142bps in 2022 and later soared 3843bps in 2025.
  • Year by year, EBIT Margin stood at 7.86% in 2021, then plummeted by -272bps to 13.56% in 2022, then plummeted by -52bps to 20.58% in 2023, then decreased by -20bps to 24.67% in 2024, then surged by 156bps to 13.76% in 2025.
  • Business Quant data shows EBIT Margin for MMSI at 13.76% in Q4 2025, 11.09% in Q3 2025, and 12.26% in Q2 2025.